Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Anemia, Refractory, with Excess of Blasts 115Myelodysplastic Syndromes 107Leukemia 98Leukemia, Myeloid, Acute 92Anemia 70Leukemia, Myelomonocytic, Chronic 68Precursor Cell Lymphoblastic Leukemia-Lymphoma 67Myeloproliferative Disorders 55Leukemia, Lymphocytic, Chronic, B-Cell 52Multiple Myeloma 48Anemia, Refractory 48Thrombocytopenia 45Lymphoma 43Lymphoma, Non-Hodgkin 42Neoplasms 40Hodgkin Disease 39Primary Myelofibrosis 36Leukemia, Myeloid, Chronic-Phase 36Congenital Abnormalities 34Anemia, Aplastic 34Myelodysplastic-Myeloproliferative Diseases 33Leukemia, Myelogenous, Chronic, BCR-ABL Positive 33Leukemia, Myeloid, Accelerated Phase 32Lymphoma, Follicular 29Blast Crisis 27Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 26Burkitt Lymphoma 25Lymphoma, Mantle-Cell 24Neoplasms, Plasma Cell 23Lymphoma, B-Cell, Marginal Zone 23

Interventions

eltrombopag 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Jacobs syndrome × Classical hematology × Clear all
NCT01168921 2023-03-23

Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)

M.D. Anderson Cancer Center

Phase 2 Completed
23 enrolled 9 charts
Classical hematologyLymphoidOther hematologic neoplasm

Jacobs syndrome, Leukemia, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00102726 2017-03-23

SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy

GlaxoSmithKline

Phase 2 Completed
183 enrolled
Classical hematology

Jacobs syndrome, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡